Is IP-10 a Better Biomarker? 18. Peters W, Ernst JD (2003) Mechanisms of cell recruitment in the immune response to Mycobacterium tuberculosis. Microbes Infect 5: 151–158. 19. Alessandri AL, Souza AL, Oliveira SC, Macedo GC, Teixeira MM, et al. (2006) Concentrations of CXCL8, CXCL9 and sTNFR1 in plasma of patients with pulmonary tuberculosis undergoing treatment. Inflamm Res 55: 528–533. 20. Khader SA, Bell GK, Pearl JE, Fountain JJ, Rangel-Moreno J, et al. (2007) IL- 23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 8: 369–377. 21. Lit LC, Wong CK, Tam LS, Li EK, Lam CW (2006) Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus. Ann Rheum Dis 65: 209–215. 22. Romagnani P, Rotondi M, Lazzeri E, Lasagni L, Francalanci M, et al. (2002) Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves’ disease. Am J Pathol 161: 195–206. 23. Kawamura A, Miura S, Fujino M, Nishikawa H, Matsuo Y, et al. (2003) CXCR3 chemokine receptor-plasma IP10 interaction in patients with coronary artery disease. Circ J 67: 851–854. 24. Jinquan T, Jing C, Jacobi HH, Reimert CM, Millner A, et al. (2000) CXCR3 expression and activation of eosinophils: role of IFN-gamma-inducible protein- 10 and monokine induced by IFN-gamma. J Immunol 165: 1548–1556. 25. Guyot-Revol V, Innes JA, Hackforth S, Hinks T, Lalvani A (2006) Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med 173: 803–810. PLoS ONE | www.plosone.org 6 December 2008 | Volume 3 | Issue 12 | e3901